Massimiliano Cadamuro

14PUBLICATIONS
60CO-AUTHORS
Molecular targetsSensory systemsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 11, 2025
TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy.

Sara Bonomo, Roberto Giovannoni, Marialuisa Lavitrano

|Jun 13, 2024
Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia.

Carlo Idotta, Mario Angelo Pagano, Elena Tibaldi

|Jan 23, 2024
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids.

Adriana Romanzi, Fabiola Milosa, Gemma Marcelli

|Sep 28, 2023
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models.

Paolo Rainone, Silvia Valtorta, Chiara Villa

|Sep 13, 2023
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease.

Scott H Waddell, Yuelin Yao, Paula Olaizola

|Mar 11, 2023
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma.

Massimiliano Cadamuro, Samantha Sarcognato, Riccardo Camerotto

Pageof 3

Frequent Collaborators

5 joint publications

Luca Fabris

2 joint publications

Angela Bentivegna

2 joint publications

Marialuisa Lavitrano

2 joint publications

Donatella Conconi